On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Intuitive Surgical, Inc. (NASDAQ:ISRG).
On Oct. 17, Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion. The robotic-assisted surgery company reported third-quarter adjusted earnings of $1.84 per share, beating analyst estimates of $1.63 per share, according to Benzinga Pro.
Kimco Realty Corporation (NYSE:KIM) is a “great operator, just own it right through,” he said.
On Oct. 1, Kimco Realty announced the acquisition of Waterford Lakes Town Center, a 976,000-square-foot signature asset spanning 79 acres in Orlando, Florida, for $322 million, including the assumption of a $164 million mortgage.
“That is such a hard story to understand,” Cramer said when asked about Nutanix, Inc. (NASDAQ:NTNX).
On Oct. 28, Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $71 to $72.
The “Mad Money” host said CrowdStrike Holdings, Inc. (NASDAQ:CRWD) is a buy.
On Oct. 22, CrowdStrike partnered with Fortinet, Inc. (NASDAQ:FTNT) to enhance endpoint and firewall protection by integrating its AI-native security from the Falcon platform with FortiGate next-generation firewalls (NGFW).
Rocket Lab USA, Inc. (NASDAQ:RKLB) is a “high speculative” stock, he said.
On Oct. 24, Keybanc analyst Michael Leshock maintained Rocket Lab with an Overweight and raised the price target from $11 to $12.
Price Action:
- Intuitive Surgical shares gained 1.1% to settle at $516.31 on Tuesday.
- Kimco shares declined 0.9% to close at $23.67 on Tuesday.
- Nutanix shares rose 1.3% to settle at $64.97 during the session.
- CrowdStrike shares gained 3.2% to settle at $310.94 on Tuesday.
- Rocket Lab gained 1.9% to settle at $11.47 on Tuesday.
Read Next:
Photo: s_bukley/Shutterstock.com
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
